BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21997172)

  • 1. Gestational trophoblastic neoplasia and human immunodeficiency virus infection: a 10-year review.
    Tayib S; van Wijk L; Denny L
    Int J Gynecol Cancer; 2011 Dec; 21(9):1684-91. PubMed ID: 21997172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
    Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F
    Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study.
    Kong Y; Yang J; Jiang F; Zhao J; Ren T; Li J; Wang X; Feng F; Wan X; Xiang Y
    Gynecol Oncol; 2017 Jul; 146(1):81-86. PubMed ID: 28461032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ; Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.
    Gulia S; Bajpai J; Gupta S; Maheshwari A; Deodhar K; Kerkar RA; Seth V; Rekhi B; Menon S
    Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):39-44. PubMed ID: 24051171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical outcome of patients with gestational trophoblastic neoplasia receiving primary treatment at Peking Union Medical College Hospital: a 30-year retrospective cohort study].
    Jiang F; Yang Y; Ji ML; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):364-370. PubMed ID: 29961277
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum hCG level and rising world health organization score at second-line chemotherapy (pulse dactinomycin): poor prognostic factors for methotrexate-failed low-risk gestational trophoblastic neoplasia.
    Kang WD; Kim CH; Cho MK; Kim JW; Cho HY; Kim YH; Choi HS; Kim SM
    Int J Gynecol Cancer; 2010 Nov; 20(8):1424-8. PubMed ID: 21051988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of Patients with Gestational Trophoblastic Neoplasia and Obstetric Outcomes of Those Conceiving After Chemotherapy.
    Gadducci A; Cosio S; Fanucchi A; Tana R; Manacorda S; Pistolesi S; Strigini FL
    Anticancer Res; 2016 Jul; 36(7):3477-82. PubMed ID: 27354611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter analysis of gestational trophoblastic neoplasia in Turkey.
    Ozalp SS; Telli E; Oge T; Tulunay G; Boran N; Turan T; Yenen M; Kurdoglu Z; Ozler A; Yuce K; Ulker V; Arvas M; Demirkiran F; Bese T; Tokgozoglu N; Onan A; Sanci M; Gokcu M; Tosun G; Dikmen Y; Ozsaran A; Terek MC; Akman L; Yetimalar H; Kilic DS; Gungor T; Ozgu E; Yildiz Y; Kokcu A; Kefeli M; Kuruoglu S; Yuksel H; Guvenal T; Hasdemir PS; Ozcelik B; Serin S; Dolanbay M; Arioz DT; Tuncer N; Bozkaya H; Guven S; Kulaksiz D; Varol F; Yanik A; Ogurlu G; Simsek T; Toptas T; Dogan S; Camuzoglu H; Api M; Guzin K; Caliskan E; Doger E; Cakmak B; Ilhan TT
    Asian Pac J Cancer Prev; 2014; 15(8):3625-8. PubMed ID: 24870768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
    Al-Husaini H; Soudy H; Darwish A; Ahmed M; Eltigani A; Edesa W; Elhassan T; Omar A; Elghamry W; Al-Hashem H; Al-Hayli S; Madkhali I; Ahmad S; Al-Badawi IA
    Clin Transl Oncol; 2015 May; 17(5):409-15. PubMed ID: 25398721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory Gestational Trophoblastic Neoplasia: A Novel Drug Combination With Paclitaxel and Carboplatin Produces Durable Complete Remission.
    Rathod PS; Kundargi R; Pallavi VR; Vijay CR; Devi UK; Bafna UD
    Int J Gynecol Cancer; 2015 Nov; 25(9):1737-41. PubMed ID: 26401644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?
    Essel KG; Bruegl A; Gershenson DM; Ramondetta LM; Naumann RW; Brown J
    Gynecol Oncol; 2017 Jul; 146(1):74-80. PubMed ID: 28473205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary study of PD-1 inhibitor in the treatment of drug-resistant recurrent gestational trophoblastic neoplasia].
    Cheng HY; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):390-394. PubMed ID: 32842245
    [No Abstract]   [Full Text] [Related]  

  • 15. High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.
    Cagayan MS
    J Reprod Med; 2012; 57(5-6):231-6. PubMed ID: 22696818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.
    Even C; Pautier P; Duvillard P; Floquet A; Kerbrat P; Troalen F; Rey A; Balleyguier C; Tazi Y; Leary A; Augereau P; Morice P; Droz JP; Fizazi K; Lhommé C
    Eur J Cancer; 2014 Aug; 50(12):2082-9. PubMed ID: 24910417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia.
    Maestá I; Horowitz NS; Goldstein DP; Bernstein MR; Ramírez LA; Moulder J; Berkowitz RS
    Int J Gynecol Cancer; 2015 May; 25(4):734-40. PubMed ID: 25675037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of mortality among women with gestational trophoblastic disease infected with the human immunodeficiency virus (HIV): argument for a new poor prognostic factor.
    Moodley M; Budhram S; Connolly C
    Int J Gynecol Cancer; 2009 Feb; 19(2):289-93. PubMed ID: 19396011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid.
    Taylor F; Grew T; Everard J; Ellis L; Winter MC; Tidy J; Hancock BW; Coleman RE
    Eur J Cancer; 2013 Oct; 49(15):3184-90. PubMed ID: 23870384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy.
    Chapman-Davis E; Hoekstra AV; Rademaker AW; Schink JC; Lurain JR
    Gynecol Oncol; 2012 Jun; 125(3):572-5. PubMed ID: 22449733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.